63 participants
Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-04-22
- Start Date:
- 2021-07-09
- Completion:
- 2024-06-15
Conditions
- Lung Cancer
Interventions
- DRUG
No Results Yet